EMA Withdrawn: Arepanrix (split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs.) — GlaxoSmithKline Biologicals S.A.

View source ↗

Summary

EMA confirms withdrawal of Arepanrix influenza vaccine (split inactivated H1N1) by GlaxoSmithKline Biologicals S.A. with decision dated 13/08/2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diseases of Immunization and Disease Outbreaks

Drugs mentioned

• Arepanrix (Influenza vaccine (H1N1))

Snippet

Status: Withdrawn. Therapeutic area: Influenza, Human;Immunization;Disease Outbreaks. MAH: GlaxoSmithKline Biologicals S.A.. Decision date: 13/08/2010. Conditional approval